Section 2 of the Expanding Capacity for Health Outcomes Act, referred to in subsec. (f), is section 2 of Puspan. L. 114–270, Dec. 14, 2016, 130 Stat. 1395, which is not classified to the Code.

The Federal Food, Drug, and Cosmetic Act, referred to in subsec. (g)(1)(B)(i), is act June 25, 1938, ch. 675, 52 Stat. 1040, which is classified generally to chapter 9 (§ 301 et seq.) of Title 21, Food and Drugs. For complete classification of this Act to the Code, see section 301 of Title 21 and Tables.

2025—Subsec. (d)(2). Puspan. L. 119–44, § 303(1)(A), substituted “, in such manner, and containing such information and assurances, including relevant documentation,” for “and in such manner” in introductory provisions.

Subsec. (d)(2)(A). Puspan. L. 119–44, § 303(1)(B), substituted “has the demonstrated capability to carry out, through referral or contractual arrangements” for “is capable of coordinating with other entities to carry out”.

Subsec. (h). Puspan. L. 119–44, § 303(2), designated existing provisions as par. (1), inserted heading, redesignated former pars. (1) to (4) as subpars. (A) to (D), respectively, of par. (1) and realigned margins, and added par. (2).

Subsec. (j). Puspan. L. 119–44, § 303(3), substituted “2026 through 2030” for “2019 through 2023”.